SML2624

Dexlansoprazole

≥98% (HPLC), Proton pump inhibitor, powder

• Synonym(e): (R)-(+)-Lansoprazole, (R)-(+)2-([3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl)-1H-benzo[d]imidazole
• Empirische Formel (Hill-System): C₁₆H₁₄F₃N₃O₂S
• CAS-Nummer: 138530-94-6
• Molekulargewicht: 369.36
• UNSPSC Code: 12352200
• NACRES: NA.77
• MDL number: MFCD16294176
• Assay: ≥98% (HPLC)
• Form: powder

Eigenschaften

• Produktname: Dexlansoprazole, ≥98% (HPLC)
• assay: ≥98% (HPLC)
• form: powder
• optical activity: [α]/D +142 to +158°, c = 1 in chloroform-d
• color: white to beige
• solubility: DMSO: 2 mg/mL, clear
• storage temp.: 2-8°C
• InChI: 1S/C16H14F3N3O2S/c1-10-13(20-7-6-14(10)24-9-16(17,18)19)8-25(23)15-21-11-4-2-3-5-12(11)22-15/h2-7H,8-9H2,1H3,(H,21,22)/t25-/m1/s1
• InChI key: MJIHNNLFOKEZEW-RUZDIDTESA-N

Beschreibung

Biochem/physiol Actions

Dexlansoprazole is a proton pump inhibitor. It is the active enantiomer of lansoprazole used to treat gastroesophageal reflux disease (GERD).

Proton pump inhibitor; Active enantiomer of lansoprazole to treat gastroesophageal reflux disease (GERD)

Sicherheitshinweise

• Lagerklasse: 11 - Combustible Solids
• flash_point_f: Not applicable
• flash_point_c: Not applicable